Fundamental principles of an effective diabetic retinopathy screening program

COMMENTED

Retinal Diseases

Applicability of telemedicine in the screening of diabetic retinopathy (DR): The first multicentre study in Italy. The No Blind Study

Diabetes Metab Res Rev.

Sasso FC, Pafundi PC, Gelso A, Bono V, Costagliola C, Marfella R, Sardu C, Rinaldi L, Galiero R, Acierno C, de Sio C, Adinolfi LE; NO BLIND Study Group

doi: 10.1002/dmrr.3113.

Retinal Diseases

Interventions to increase attendance for diabetic retinopathy screening

Cochrane Database Syst Rev.

Lawrenson JG, Graham-Rowe E, Lorencatto F, Burr J, Bunce C, Francis JJ, Aluko P, Rice S, Vale L, Peto T, Presseau J, Ivers N, Grimshaw JM

Retinal Diseases

Validation of automated screening for referable diabetic retinopathy with the IDx-DR device in the Hoorn Diabetes Care System

Acta Ophthalmol.

van der Heijden AA, Abramoff MD, Verbraak F, van Hecke MV, Liem A, Nijpels G

doi: 10.1111/aos.13613.

Retinal Diseases

Irish National Diabetic RetinaScreen Programme: report on five rounds of retinopathy screening and screen-positive referrals. (INDEAR study report no. 1)

Br J Ophthalmol

Pandey R, Morgan MM, Murphy C, Kavanagh H, Acheson R, Cahill M, McGettrick P, O'Toole L, Hamroush F, Mooney T, Byrne H, Fitzpatrick P, Keegan DJ

doi: 10.1136/bjophthalmol-2020-317508

Retinal Diseases

Comparison of Early Treatment Diabetic Retinopathy Study Standard 7-Field Imaging With Ultrawide-Field Imaging for Determining Severity of Diabetic Retinopathy

JAMA Ophthalmol.

Aiello LP, Odia I, Glassman AR, Melia M, Jampol LM, Bressler NM, Kiss S, Silva PS, Wykoff CC, Sun JK, Diabetic Retinopathy Clinical Research Network

doi: 10.1001/jamaophthalmol.

Retinal Diseases

Racial/Ethnic Disparities and Barriers to Diabetic Retinopathy Screening in Youths

JAMA Ophthalmol

Thomas CG, Channa R, Prichett L, Liu TYA, Abramoff MD, Wolf RM

doi: 10.1001/jamaophthalmol.2021.1551

Retinal Diseases

Ten-year incidence and assessment of safe screening intervals for diabetic retinopathy: the OPHDIAT study

Br J Ophthalmol.

Chamard C, Daien V, Erginay A, Gautier JF, Villain M, Tadayoni R, Carriere I, Massin P

doi: 10.1136/bjophthalmol-2020-316030.

Retinal Diseases

Effectiveness of Teleretinal Imaging-Based Hospital Referral Compared With Universal Referral in Identifying Diabetic Retinopathy: A Cluster Randomized Clinical Trial

JAMA Ophthalmol.

Joseph S, Kim R, Ravindran RD, Fletcher AE, Ravilla TD

doi: 10.1001/jamaophthalmol.

Retinal Diseases

Evaluation of Diabetic Retinal Screening and Factors for Ophthalmology Referral in a Telemedicine Network

JAMA Ophthalmol.

Jani PD, Forbes L, Choudhury A, Preisser JS, Viera AJ, Garg S

doi: 10.1001/

Related content

Applicability of telemedicine in the screening of diabetic retinopathy (DR): The first multicentre study in Italy. The No Blind Study

Interventions to increase attendance for diabetic retinopathy screening

Validation of automated screening for referable diabetic retinopathy with the IDx-DR device in the Hoorn Diabetes Care System

Irish National Diabetic RetinaScreen Programme: report on five rounds of retinopathy screening and screen-positive referrals. (INDEAR study report no. 1)

Comparison of Early Treatment Diabetic Retinopathy Study Standard 7-Field Imaging With Ultrawide-Field Imaging for Determining Severity of Diabetic Retinopathy

Racial/Ethnic Disparities and Barriers to Diabetic Retinopathy Screening in Youths

Ten-year incidence and assessment of safe screening intervals for diabetic retinopathy: the OPHDIAT study

Effectiveness of Teleretinal Imaging-Based Hospital Referral Compared With Universal Referral in Identifying Diabetic Retinopathy: A Cluster Randomized Clinical Trial

Evaluation of Diabetic Retinal Screening and Factors for Ophthalmology Referral in a Telemedicine Network